.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,294,535

« Back to Dashboard

Details for Patent: 6,294,535

Title: Uracil derivatives and antitumor effect potentiator and antitumor agent containing the same
Abstract:The invention relates to novel uracil derivatives having excellent inhibiting effects on human derived thymidine phosphorylates and anti-tumor activity. The pharmaceutical compositions, anti-tumor potentiators and antitumor agents containing such novel compounds, and a process for their preparation and use are described. The novel uracil derivative compounds are represented by the general formula (1'): ##STR1##
Inventor(s): Yano; Shingo (Kawagoe, JP), Tada; Yukio (Higashimatsuyama, JP), Kazuno; Hideki (Hanno, JP), Sato; Tsutomu (Hanno, JP), Yamashita; Junichi (Honjo, JP), Suzuki; Norihiko (Hidaka, JP), Emura; Tomohiro (Iruma, JP), Fukushima; Masakazu (Hanno, JP), Asao; Tetsuji (Tokorozawa, JP)
Assignee: Taiho Pharmaceutical Co., Ltd. (Tokyo, JP)
Filing Date:Dec 09, 1999
Application Number:09/457,668
Claims:1. A pharmaceutical composition comprising:

a uracil derivative represented by the following formula (1): ##STR170##

wherein R.sup.1 is selected from the group consisting of chlorine, bromine, iodine, cyano and a lower alkyl group; and R.sup.2 represents an amino group, one or both of the hydrogen atoms on the nitrogen atom of which may each be substituted by a lower alkyl group; or a salt thereof; and

a pharmaceutically acceptable carrier.

2. The uracil derivative of claim 1, wherein R.sup.1 is chlorine or iodine.

3. The uracil derivative of claim 1, wherein R.sup.1 is cyano.

4. The uracil derivative of claim 1, wherein R.sup.1 is a lower alkyl group.

5. The uracil derivative of claim 1, wherein R.sup.2 is an amino group with one or both of the hydrogen atoms on the nitrogen atom substituted by a lower alkyl group.

6. method for potentiating an antitumor effect of an antitumor agent containing a 2'deoxypyrmidine nucleoside, which comprises administering to a patient an effective amount of an uracil derivative represented by the following formula (1): ##STR171##

wherein R.sup.1 is selected from the group consisting of chlorine, bromine, iodine, cyano and a lower alkyl group; and R.sup.2 represents an amino group, one or both of the hydrogen atoms on the nitrogen atom of which may each be substituted by a lower alkyl group; or a salt thereof.

7. The uracil derivative of claim 6, wherein R.sup.1 is chlorine or iodine.

8. The uracil derivative of claim 6, wherein R.sup.1 is cyano.

9. The uracil derivative of claim 6, wherein R.sup.1 is a lower alkyl group.

10. The uracil derivative of claim 6, wherein R.sup.2 is an amino group with one or both of the hydrogen atoms on the nitrogen atom substituted by a lower alkyl group.

11. A therapeutic method for treating cancer, which comprises administering to a patient in need of treatment an effective amount of a uracil derivative represented by the following formula (1): ##STR172##

wherein R.sup.1 is selected from the group consisting of chlorine, bromine, iodine, cyano and a lower alkyl group; and R.sup.2 represents an amino group, one or both of the hydrogen atoms on the nitrogen atom of which may each be substituted by a lower alkyl group; or a salt thereof; and a 2'-deoxypyrimidine nucleoside.

12. The uracil derivative of claim 11, wherein R.sup.1 is chlorine or iodine.

13. The uracil derivative of claim 11, wherein R.sup.1 is cyano.

14. The uracil derivative of claim 11, wherein R.sup.1 is a lower alkyl group.

15. The uracil derivative of claim 11, wherein R.sup.2 is an amino group with one or both of the hydrogen atoms on the nitrogen atom substituted by a lower alkyl group.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc